대한갑상선학회 갑상선분화암 진료권고안; 개요 및 요약 2024

키워드

참고문헌 (52)

1. Chen DW, "Thyroid cancer", Lancet, 401(10387), pp.1531~1544 (2023)
2. Nabhan F, "Thyroid cancer, recent advances in diagnosis and therapy", Int J Cancer, 149(5), pp.984~992 (2021)
3. Kitahara CM, "Epidemiology of thyroid cancer", Cancer Epidemiol Biomarkers Prev, 31(7), pp.1284~1297 (2022)
4. Kim WB, "Management guidelines for patients with thyroid nodules and thyroid cancer", J Korean Endocr Soc, 22(3), pp.157~187 (2007)
5. Haugen BR, "2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer : the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer", Thyroid, 26(1), pp.1~133 (2016)
6. Yi KH, "Revised Korean Thyroid Association management guidelines for patients with thyroid nodules and thyroid cancer", J Korean Thyroid Assoc, 3(2), pp.65~96 (2010)
7. Yi KH, "The revised 2016 Korean Thyroid Association guidelines for thyroid nodules and cancers : differences from the 2015American Thyroid Association guidelines", Endocrinol Metab(Seoul), 31(3), pp.373~378 (2016)
8. Yi KH, "2016 revised Korean Thyroid Association management guidelines for patients with thyroid nodules and thyroid cancer", Int J Thyroidol, 9(2), pp.59~126 (2016)
9. Park YJ, "2023 Korean Thyroid Association management guidelines for patients with thyroid nodules", Int J Thyroidol, 16(1), pp.1~31 (2023)
10. Ali SZ, "The 2023 Bethesda system for reporting thyroid cytopathology", J Am Soc Cytopathol, 12(5), pp.319~325 (2023)
11. Ali SZ, "The 2023 Bethesda system for reporting thyroid cytopathology", Thyroid, 33(9), pp.1039~1044 (2023)
12. Ha EJ, "2021 Korean Thyroid Imaging Reporting and Data System and imaging-based management of thyroid nodules : Korean Society of Thyroid Radiology consensus statement and recommendations", Korean J Radiol, 22(12), pp.2094~2123 (2021)
13. Jung CK, "2019practice guidelines for thyroid core needle biopsy : a report of the Clinical Practice Guidelines Development Committee of the Korean Thyroid Association", J Pathol Transl Med, 54(1), pp.64~86 (2020)
14. Park JO, "Guideline for the surgical management of locally invasive differentiated thyroid cancer from the Korean Society of Head and Neck Surgery", Clin Exp Otorhinolaryngol, 16(1), pp.1~19 (2023)
15. Aschebrook-Kilfoy B, "Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006", Thyroid, 21(2), pp.125~134 (2011)
16. Mazzaferri EL, "Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer", Am J Med, 97(5), pp.418~428 (1994)
17. "Cancer", 1998, 2638~2648
18. Mazzaferri EL, "An overview of the management of papillary and follicular thyroid carcinoma", Thyroid, 9(5), pp.421~427 (1999)
19. Mazzaferri EL, "Long-term outcome of patients with differentiated thyroid carcinoma : effect of therapy", Endocr Pract, 6(6), pp.469~476 (2000)
20. Cooper DS, "Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer : results from the National Thyroid Cancer Treatment Cooperative Registry", Thyroid, 8(9), pp.737~744 (1998)
21. Hay ID, "Predicting outcome in papillary thyroid carcinoma : development of a reliable prognostic scoring system in a cohort of 1779patients surgically treated at one institution during 1940 through 1989", Surgery, 114(6), pp.1050~1057 (1993)
22. Shah MD, "Clinical course of thyroid carcinoma after neck dissection", Laryngoscope, 113(12), pp.2102~2107 (2003)
23. Wang TS, "Incidence of metastatic well-differentiated thyroid cancer in cervical lymph nodes", Arch Otolaryngol Head Neck Surg, 130(1), pp.110~113 (2004)
24. Lin JD, "Use of radioactive iodine for thyroid remnant ablation in welldifferentiated thyroid carcinoma to replace thyroid reoperation", Am J Clin Oncol, 21(1), pp.77~81 (1998)
25. Brierley JD, "A comparison of different staging systems predictability of patient outcome. Thyroid carcinoma as an example", Cancer, 79(12), pp.2414~2423 (1997)
26. Hay ID, "Papillary thyroid carcinoma managed at the Mayo Clinic during six decades(1940-1999) : temporal trends in initial therapy and long-term outcome in 2444consecutively treated patients", World J Surg, 26(8), pp.879~885 (2002)
27. Sosa JA, "The importance of surgeon experience for clinical and economic outcomes from thyroidectomy", Ann Surg, 228(3), pp.320~330 (1998)
28. Loyo M, "National trends in thyroid surgery and the effect of volume on short-term outcomes", Laryngoscope, 123(8), pp.2056~2063 (2013)
29. Stavrakis AI, "Surgeon volume as a predictor of outcomes in inpatient and outpatient endocrine surgery", Surgery, 142(6), pp.887~899 (2007)
30. Links TP, "Life expectancy in differentiated thyroid cancer : a novel approach to survival analysis", Endocr Relat Cancer, 12(2), pp.273~280 (2005)
31. Kim S, "Predicting outcome and directing therapy for papillary thyroid carcinoma", Arch Surg, 139(4), pp.390~394 (2004)
32. Bogdanovski AK, "Financial toxicity in thyroid cancer survivors", Curr Opin Endocrinol Diabetes Obes, 30(5), pp.238~243 (2023)
33. Mongelli MN, "Financial burden and quality of life among thyroid cancer survivors", Surgery, 167(3), pp.631~637 (2020)
34. Ronga G, "Lung metastases from differentiated thyroid carcinoma. A 40 years' experience", Q J Nucl Med Mol Imaging, 48(1), pp.12~19 (2004)
35. Schlumberger M, "Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma", J Nucl Med, 37(4), pp.598~605 (1996)
36. Bernier MO, "Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas", J Clin Endocrinol Metab, 86(4), pp.1568~1573 (2001)
37. Zettinig G, "Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma -- surgery or conventional therapy?", Clin Endocrinol (Oxf), 56(3), pp.377~382 (2002)
38. Chiu AC, "Prognosis and treatment of brain metastases in thyroid carcinoma", J Clin Endocrinol Metab, 82(11), pp.3637~3642 (1997)
39. Lin JD, "Papillary thyroid carcinomas with lung metastases", Thyroid, 14(12), pp.1091~1096 (2004)
40. Shoup M, "Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma", J Am Coll Surg, 197(2), pp.191~197 (2003)
41. Pittas AG, "Bone metastases from thyroid carcinoma : clinical characteristics and prognostic variables in one hundred forty-six patients", Thyroid, 10(3), pp.261~268 (2000)
42. Dinneen SF, "Distant metastases in papillary thyroid carcinoma : 100 cases observed at one institution during 5decades", J Clin Endocrinol Metab, 80(7), pp.2041~2045 (1995)
43. Eustatia-Rutten CF, "Outcome of palliative embolization of bone metastases in differentiated thyroid carcinoma", J Clin Endocrinol Metab, 88(7), pp.3184~3189 (2003)
44. Foote RL, "Is there a role for radiation therapy in the management of Hurthle cell carcinoma?", Int J Radiat Oncol Biol Phys, 56(4), pp.1067~1072 (2003)
45. Pak H, "Role of metastasectomy in the management of thyroid carcinoma : the NIH experience", J Surg Oncol, 82(1), pp.10~18 (2003)
46. Vitale G, "Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer", Br J Cancer, 84(12), pp.1586~1590 (2001)
47. Kitamura Y, "Immediate causes of death in thyroid carcinoma : clinicopathological analysis of 161 fatal cases", J Clin Endocrinol Metab, 84(11), pp.4043~4049 (1999)
48. Lee YA, "Pediatric patients with multifocal papillary thyroid cancer have higher recurrence rates than adult patients : a retrospective analysis of a large pediatric thyroid cancer cohort over 33 years", J Clin Endocrinol Metab, 100(4), pp.1619~1629 (2015)
49. Redlich A, "Age, American Thyroid Association risk group, and response to therapy are prognostic factors in children with differentiated thyroid cancer", J Clin Endocrinol Metab, 107(1), pp.e165~e177 (2022)
50. Rangel-Pozzo A, "Genetic landscape of papillary thyroid carcinoma and nuclear architecture : an overview comparing pediatric and adult populations", Cancers(Basel), 12(11), pp.3146~ (2020)
51. van de Berg DJ, "Long-term oncological outcomes of papillary thyroid cancer and follicular thyroid cancer in children : a nationwide populationbased study", Front Endocrinol(Lausanne), 13, pp.899506~ (2022)
52. Lee YA, "Predominant DICER1 pathogenic variants in pediatric follicular thyroid carcinomas", Thyroid, 30(8), pp.1120~1131 (2020)

관련 논문AI추천